These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14700591)

  • 1. The HLA-DR phenotype of the responder is predictive of humoral response against HLA class I antigens.
    Dankers MK; Roelen DL; Nagelkerke NJ; de Lange P; Persijn GG; Doxiadis II; Claas FH
    Hum Immunol; 2004 Jan; 65(1):13-9. PubMed ID: 14700591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA phenotypes of ESRD patients are risk factors in the panel-reactive antibody (PRA) response.
    Heise E; Manning C; Thacker L
    Clin Transplant; 2001; 15 Suppl 6():22-7. PubMed ID: 11903382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I peptides involved in the indirect pathway of allorecognition.
    Takemoto SK; Cecka JM; Gjertson DW; Terasaki PI
    Transplant Proc; 1999; 31(1-2):781. PubMed ID: 10083332
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation.
    Kosmoliaptsis V; Gjorgjimajkoska O; Sharples LD; Chaudhry AN; Chatzizacharias N; Peacock S; Torpey N; Bolton EM; Taylor CJ; Bradley JA
    Kidney Int; 2014 Nov; 86(5):1039-48. PubMed ID: 24717292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques.
    Piazza A; Poggi E; Borrelli L; Servetti S; Monaco PI; Buonomo O; Valeri M; Torlone N; Adorno D; Casciani CU
    Transplantation; 2001 Apr; 71(8):1106-12. PubMed ID: 11374411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of donor-specific anti-human leukocyte antigen antibodies after the transplantation of a fully matched kidney allograft and its impact on the selection of a subsequent renal regraft: a case report.
    Schlaf G; Radam C; Wahle A; Altermann WW
    Transplant Proc; 2012 Jun; 44(5):1442-5. PubMed ID: 22664032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis.
    Burlingham WJ; Jankowska-Gan E; VanBuskirk A; Orosz CG; Lee JH; Kusaka S
    Hum Immunol; 2000 Dec; 61(12):1395-402. PubMed ID: 11163098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigens DR and AB and kidney retransplantation.
    Thompson JS; Thacker LR; Krishnan G
    Transplantation; 2003 Mar; 75(5):718-23. PubMed ID: 12640315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative cross-match selection of HLA-DR compatible kidneys for highly sensitised patients.
    Claas FH
    Immunol Lett; 1991 Jul; 29(1-2):61-4. PubMed ID: 1916926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance.
    Smith JD; Hornick PI; Rasmi N; Rose ML; Yacoub MH
    Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S212-5. PubMed ID: 9930450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder.
    Fuller TC; Fuller A
    Transplantation; 1999 Jul; 68(2):173-82. PubMed ID: 10440383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.
    Hyun J; Park KD; Yoo Y; Lee B; Han BY; Song EY; Park MH
    Transplant Proc; 2012 Jan; 44(1):222-5. PubMed ID: 22310619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperimmunized patients do not need to wait for an HLA identical donor.
    Claas FH; van Leeuwen A; van Rood JJ
    Tissue Antigens; 1989 Jul; 34(1):23-9. PubMed ID: 2683206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinations.
    Lardy NM; van der Horst AR; ten Berge IJ; Surachno S; Wilmink JM; de Waal LP
    Transplantation; 1997 Aug; 64(4):612-6. PubMed ID: 9293875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
    Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
    Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of positive PRA on the results of ABO-incompatible kidney transplantation.
    Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Toma H
    Transplant Proc; 2004 Sep; 36(7):2169-71. PubMed ID: 15518789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.